SCHEMBL24775949

SCHEMBL24775949

CC(C)(C)N1CCCC1(C)c1ccccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 5/20 0.36
GRIN2A Q12879 5/20 0.36
GRIN2D O15399 3/20 0.36
GRIN3B O60391 3/20 0.36
GRIN2B Q13224 3/20 0.36
GRIN2C Q14957 3/20 0.36
GRIN3A Q8TCU5 3/20 0.36
SLC6A4 P31645 2/20 0.36
OPRM1 P35372 2/20 0.36
OPRK1 P41145 1/20 0.36
LMNA P02545 1/20 0.36
CACNA1C Q13936 1/20 0.36
HDAC4 P56524 1/20 0.36
TAAR1 Q96RJ0 1/20 0.34
CCR1 P32246 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
KCNH2 Q12809 1/20 0.33
SIGMAR1 Q99720 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24775947 0.78 PDK2 (0.35) CHRM4CHRM2CHRM1
SCHEMBL24775958 0.75 GRIN1 (0.34) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL6072282 0.73 KDM1A (0.42) GRIN2BGRIN2CHDAC4
SCHEMBL31444388 0.73 KDM1A (0.42) GRIN2BGRIN2CHDAC4
SCHEMBL24775953 0.71 SIGMAR1 (0.33) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL802999 0.69 GRIN1 (0.41) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL803385 0.69 GRIN1 (0.45) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL803639 0.69 GRIN1 (0.40) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL17886563 0.67 OPRM1 (0.47) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL15621614 0.66 GRIN1 (0.49) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402915-A1 BCL-2 INHIBITORS BEONE MEDICINES I GMBH (CH) 2022-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402915-A1 BCL-2 INHIBITORS BCL2, BCL2L1, BCL2L2 GRIN1 3971/4885GRIN2A 3354/4885GRIN2D 4153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.